Literature DB >> 2139501

Neurotensin reduces the affinity of dopamine D2 receptors in membranes from post mortem human caudate-putamen.

G von Euler1, P Mailleux, J J Vanderhaeghen, K Fuxe.   

Abstract

The effects of neurotensin in vitro were investigated on the binding characteristics of N-[3H]propylnorapomorphine [( 3H]NPA) binding sites in crude membrane preparations from post mortem human caudate-putamen, obtained within 10 h after death from 3 patients without reported neurological or psychiatric diseases. Neurotensin (0.1-30 nM) was found to increase the KD value of [3H]NPA binding sites with a maximal increase of about 50% (420 +/- 45 pM) at 3 nM of neurotensin, without significantly affecting the Bmax value (123 +/- 20 pmol/g protein). These results indicate the existence of an intramembrane regulation by neurotensin receptors of D2 receptors in the human caudate-putamen.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139501     DOI: 10.1016/0304-3940(90)90016-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  5 in total

1.  Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.

Authors:  Susanne Koschatzky; Nuska Tschammer; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2011-04-11       Impact factor: 4.418

Review 2.  The role of neurotensin in central nervous system pathophysiology: what is the evidence?

Authors:  Fannie St-Gelais; Claudia Jomphe; Louis-Eric Trudeau
Journal:  J Psychiatry Neurosci       Date:  2006-07       Impact factor: 6.186

Review 3.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

Review 4.  Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Authors:  Louise M Paterson; Robin J Tyacke; David J Nutt; Gitte M Knudsen
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-28       Impact factor: 6.200

5.  Blockade of neurotensin-induced motor activity by inhibition of protein kinase.

Authors:  P W Kalivas
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.